Translational Gene Editing Track Header

Gene editing, particularly using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 system, is now being extensively used as a research and functional screening tool in drug discovery. Cambridge Healthtech Institute’s second annual conference on Translational Gene Editing will bring together experts from all aspects of preclinical research, from early target discovery to drug delivery, to talk about the progress being made in gene editing and how it’s being applied. Learn about ways in which CRISPR/Cas9 is being used to identify targets, create relevant cell lines and in vivo disease models, set up functional screens, and for targeted drug delivery. What can you do to overcome some of the inherent challenges with design, delivery and off-target effects associated with CRISPR/Cas9? Hear from experts in pharma/biotech, academic and government labs who will share their experiences leveraging the utility of gene editing for diverse applications, particularly in oncology and immunotherapy.

Who should attend: Students, Post-docs, Lab Technicians, Managers, Scientists, Clinicians, Team Leads, Directors and Executives from Pharma, Biotech, Academia, Government, Contract Research Labs and Technology Providers involved in Drug Discovery, Functional Screening, High-throughput Screening, Assay Development and Translational Research.

Topics will include, but are not limited to:

  • Comparing gene editing tools: CRISPRs, TALENs, ZFNs and more
  • Understanding mode-of-action and limitations of the CRISPR/Cas system
  • Setting up high-throughput and phenotypic screens
  • Creating relevant cell lines and knock-out models for disease modeling
  • Exploring gene editing in physiologically relevant systems such as stem cells and 3D cells
  • Tackling challenges with off-target effects
  • Engineering specificity and precision in delivery and efficacy

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is November 9, 2015.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions or suggestions about the meeting, please contact:
Tanuja Koppal, Ph.D.
Conference Director
Cambridge Healthtech Institute
T: (+1) 973-525-4667

For sponsorship and exhibit sales information including sponsored podium presentations, contact:
Joseph Vacca
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431




WPC Quotes